FYERS
Home
/
Stocks
/
Results
/
Beryl Drugs Results

Beryl Drugs Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
5%11%13%-21%
21%65%--25%
-14%4%4%
5%4%8%6%

Peer Comparison

Symbol
SUNPHARMA-A
DIVISLAB-A
TORNTPHARM-A
ZYDUSLIFE-A
CIPLA-A
LAURUSLABS-A
MANKIND-A
DRREDDY-A
AUROPHARMA-A
LUPIN-A
BERLDRG-X
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,853₹447476 Cr3712.0762.82₹11479 Cr
9,613₹254764 Cr87.134.04128.41₹2568 Cr
4,935₹189423 Cr86.8516.7297.06₹2163 Cr
1,180₹116658 Cr25.859.4262.53₹5040 Cr
1,404₹111484 Cr33.089.7757.87₹3879 Cr
2,026.25₹109943 Cr100.556.829.25₹889 Cr
2,475₹101712 Cr49.7913.7571.08₹1913 Cr
1,200.4₹101005 Cr31.355.3263.99₹4196 Cr
1,720₹99253 Cr26.7317.9596.84₹3505 Cr
2,098₹96031 Cr17.3730.95154.35₹5333 Cr
23.96₹12 Cr19.490.444.05₹43 L

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Long-Term Borrowings
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008Mar 2007
———————————————————
₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr
₹4 Cr₹4 Cr₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹67 L₹58 L₹50 L₹48 L₹46 L₹44 L
₹4 Cr₹4 Cr₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹67 L₹58 L₹50 L₹48 L₹46 L₹44 L
₹10 Cr₹9 Cr₹8 Cr₹7 Cr₹8 Cr₹8 Cr₹8 Cr₹7 Cr₹7 Cr₹7 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹5 Cr₹5 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹33,000₹0₹0₹0₹0
₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹7 L₹9 L₹35,291₹2 L₹0₹0₹0₹0₹79 L₹93 L₹76 L₹67 L
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹33,000₹33,000₹2 L₹5 L₹11 L
-₹61,000-₹10 L-₹13 L-₹19 L₹21 L₹8 L-₹8 L-₹3 L-₹28 L-₹24 L-₹20 L-₹13 L-₹13 L-₹13 L-₹12 L-₹12 L-₹10 L-₹9 L-₹6 L
₹42 L₹40 L₹40 L₹36 L₹31 L₹27 L₹21 L₹18 L₹21 L₹22 L₹19 L₹15 L₹13 L₹8 L₹6 L₹0₹0₹0₹0
₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹1 Cr₹23 L₹3 L-₹2 L₹68,726₹2 L-₹31,278-₹5 L-₹5 L₹68 L₹85 L₹71 L₹72 L
———————————————————
₹1 Cr₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹74 L₹2 Cr₹1 Cr₹1 Cr₹2 Cr₹1 Cr₹97 L₹1 Cr₹65 L₹98 L
₹61 L₹88 L₹1 Cr₹2 Cr₹4 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹74 L₹79 L₹15 L₹14 L₹6 L₹2 L₹36 L₹4 L₹24 L₹31 L
₹2 Cr₹3 Cr₹2 Cr₹4 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹89 L₹89 L₹1 Cr₹0₹0₹0₹0
₹32 L₹50 L₹20 L₹3 L₹7 L₹3 L₹1 L₹75,566₹8 L₹10 L₹10 L₹13 L₹22 L₹5 L₹5 L₹9 L₹4 L₹0₹0
₹4 Cr₹6 Cr₹6 Cr₹9 Cr₹8 Cr₹7 Cr₹6 Cr₹4 Cr₹4 Cr₹3 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹1 Cr₹1 Cr₹90 L₹1 Cr
₹16 Cr₹18 Cr₹17 Cr₹18 Cr₹19 Cr₹17 Cr₹14 Cr₹11 Cr₹11 Cr₹10 Cr₹11 Cr₹10 Cr₹9 Cr₹8 Cr₹8 Cr₹8 Cr₹7 Cr₹7 Cr₹7 Cr
₹0₹80 L₹1 Cr₹1 Cr₹1 Cr₹44 L₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹3 L₹3 L₹96 L₹96 L₹1 Cr₹1 Cr₹0₹0
₹4 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹5 Cr₹3 Cr₹1 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹89 L₹89 L₹1 Cr₹80 L₹95 L₹80 L₹77 L
———————————————————
₹13 Cr₹12 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹3 Cr₹3 Cr₹9 Cr₹9 Cr₹9 Cr₹8 Cr₹8 Cr₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹6 Cr₹6 Cr
₹7 Cr₹6 Cr₹5 Cr₹4 Cr₹3 Cr₹2 Cr₹87 L₹62 L₹7 Cr₹7 Cr₹6 Cr₹6 Cr₹5 Cr₹5 Cr₹5 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr
₹6 Cr₹6 Cr₹6 Cr₹6 Cr₹7 Cr₹8 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr
₹0₹0₹0₹0₹0₹0₹6 Cr₹8 L₹0₹0₹24 L₹13 L₹0₹43 L₹7 L₹0₹10,000₹0₹3 L
₹0₹0₹15 L₹16 L₹12 L₹82 L₹77 L₹39 L₹68 L₹68 L₹68 L₹68 L₹68 L₹68 L₹68 L₹68 L₹68 L₹68 L₹68 L
₹0₹0₹15 L₹16 L₹12 L₹82 L₹77 L₹39 L₹68 L₹68 L₹68 L₹68 L₹68 L₹68 L₹68 L₹68 L₹68 L₹68 L₹68 L
₹23 L₹97 L₹79 L₹90 L₹85 L₹6 L₹24 L₹1 Cr₹78 L₹81 L₹95 L₹1 Cr₹1 Cr₹72 L₹71 L₹0₹0₹0₹0
₹48 L₹12 L₹3 L₹60,000₹0₹17 L₹17 L₹12 L₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0
₹7 Cr₹7 Cr₹7 Cr₹7 Cr₹8 Cr₹9 Cr₹9 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹5 Cr₹5 Cr₹4 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr
———————————————————
₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹0₹6 L₹56 L₹24 L₹0₹0₹0₹0₹0
₹2 Cr₹1 Cr₹1 Cr₹3 Cr₹2 Cr₹1 Cr₹76 L₹1 Cr₹3 Cr₹2 Cr₹2 Cr₹1 Cr₹84 L₹1 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr
₹5 Cr₹8 Cr₹7 Cr₹4 Cr₹5 Cr₹3 Cr₹3 Cr₹5 Cr₹4 Cr₹4 Cr₹4 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr
₹81 L₹12 L₹57 L₹67 L₹45 L₹40 L₹10 L₹14 L₹77 L₹63 L₹82 L₹19 L₹25 L₹16 L₹7 L₹5 L₹15 L₹6 L₹28 L
₹34 L₹7 L₹10 L₹91 L₹2 Cr₹2 Cr₹94 L₹16 L₹13 L₹7 L₹10,191₹10,191₹18,020₹49,014₹40,636₹10 L₹0₹0₹0
₹62 L₹1 Cr₹2 Cr₹1 Cr₹94 L₹60 L₹16 L₹50 L₹16 L₹19 L₹40 L₹67 L₹13 L₹15 L₹14 L₹80 L₹89 L₹1 Cr₹99 L
₹9 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹8 Cr₹5 Cr₹7 Cr₹7 Cr₹6 Cr₹6 Cr₹5 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr₹4 Cr
₹5 Cr₹4 Cr₹4 Cr₹2 Cr₹2 Cr₹89 L-₹13 L₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹3 Cr
₹16 Cr₹18 Cr₹17 Cr₹18 Cr₹19 Cr₹17 Cr₹14 Cr₹11 Cr₹11 Cr₹10 Cr₹11 Cr₹10 Cr₹9 Cr₹8 Cr₹8 Cr₹8 Cr₹7 Cr₹7 Cr₹7 Cr
₹19₹18₹16₹14₹16₹15₹15₹13₹13₹13₹13₹13₹12₹11₹11₹11₹11₹11₹11
₹19₹18₹16₹14₹16₹15₹15₹13₹13₹13₹13₹13₹12₹11₹11₹11₹11₹11₹11

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014Mar 2013Mar 2012Mar 2011Mar 2010Mar 2009Mar 2008Mar 2007
₹87 L₹1 Cr₹98 L-₹95 L₹35 L₹16 L₹80 L₹1 Cr₹17 L₹27 L₹17 L₹43 L₹65 L₹12 L₹13 L₹8 L₹3 L₹7 L₹9 L
₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹83 L₹28 L-₹39 L₹40 L₹66 L₹96 L₹75 L₹71 L₹47 L₹41 L₹39 L₹43 L₹41 L₹42 L
₹31 L-₹2 Cr₹35 L-₹85 L-₹1 Cr-₹66 L₹3 Cr-₹87 L-₹13 L-₹54 L₹14 L-₹90 L-₹50 L₹22 L-₹28 L-₹3 L-₹9 L-₹22 L₹5 L
₹3 Cr₹1 Cr₹2 Cr-₹44 L₹36 L₹33 L₹4 Cr₹74,144₹44 L₹38 L₹1 Cr₹28 L₹87 L₹81 L₹25 L₹44 L₹37 L₹27 L₹56 L
₹3 Cr₹82 L₹2 Cr-₹47 L₹34 L₹18 L₹3 Cr-₹10 L₹27 L-₹13 L₹70 L-₹32 L₹79 L₹77 L₹20 L₹41 L₹34 L₹24 L₹54 L
-₹40 L-₹1 Cr-₹1 Cr₹52 L₹26 L-₹2 Cr-₹5 Cr-₹3 L₹5 L₹17 L₹2 L₹30 L-₹71 L-₹70 L-₹29 L-₹23 L-₹30 L-₹40 L-₹29 L
-₹2 Cr₹10 L-₹1 Cr-₹24 L-₹54 L₹2 Cr₹2 Cr-₹36 L-₹19 L-₹23 L-₹9 L-₹12 L₹9 L₹2 L₹11 L-₹27 L₹4 L-₹6 L-₹27 L
₹69 L-₹16 L₹1 L-₹18 L₹6 L₹30 L-₹4 L-₹49 L₹13 L-₹19 L₹63 L-₹14 L₹17 L₹9 L₹2 L-₹10 L₹9 L-₹22 L-₹2 L
₹12 L₹28 L₹27 L₹45 L₹40 L₹10 L₹14 L₹63 L₹63 L₹82 L₹19 L₹33 L₹16 L₹7 L₹5 L₹15 L₹6 L₹28 L₹30 L
₹81 L₹12 L₹28 L₹27 L₹45 L₹40 L₹10 L₹14 L₹77 L₹63 L₹82 L₹19 L₹33 L₹16 L₹7 L₹5 L₹15 L₹6 L₹28 L

Fundamental Ratios

Consolidated
Standalone

Share Price Live Stats

Open (₹)23.98
Volume (₹)365.00
High (₹)23.98
Upper Circuit28.77
Low (₹)22.60
Lower Circuit19.19
Prev Close23.98
52W High (₹)27.60
Price23.96
52W Low (₹)15.92

Share Market Cap & Key Ratios Overview

M.Cap (₹)12.16 Cr
Div. Yield (%)0.00
PE Ratio19.49
Debt to Equity0.43
Price to Book1.13
Book Value18.70
EPS (TTM)1.23
Face Value10.00
ROE (%)6.30

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
LUPIN-ANSE
BERLDRG-XNSE
LTP
1W Low
1W High
Market cap (₹)
1853+17.5 (0.95%)
1835.50
1890.40
4,47,476Cr
9613+246 (2.63%)
9305.95
9739.85
2,54,764Cr
4935+130.75 (2.72%)
4864.80
5010
1,89,423Cr
1180+27 (2.34%)
1152
1191
1,16,658Cr
1404+32.55 (2.37%)
1364
1418.70
1,11,484Cr
2026.25+71 (3.63%)
1964.50
2054.55
1,09,943Cr
2475+157 (6.77%)
2302.30
2503.20
1,01,712Cr
1200.4+29.3 (2.50%)
1186.20
1221.60
1,01,005Cr
1720-15 (-0.86%)
1690
1739.60
99,253Cr
2098-46.7 (-2.18%)
2084.50
2129.85
96,031Cr
23.96+0.27 (1.14%)
22
24.25
12Cr

Beryl Drugs Ltd Annual Results Key Takeaways

Basis: Consolidated annual results.

Beryl Drugs Ltd Quaterly Results Key Takeaways